Huntleigh Advisors Inc. Has $783,000 Stock Position in Cellebrite DI Ltd. $CLBT

Huntleigh Advisors Inc. raised its stake in Cellebrite DI Ltd. (NASDAQ:CLBT) by 3.9% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 48,950 shares of the company’s stock after buying an additional 1,821 shares during the quarter. Huntleigh Advisors Inc.’s holdings in Cellebrite DI were worth $783,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Assetmark Inc. acquired a new stake in shares of Cellebrite DI during the first quarter worth $33,000. Signaturefd LLC increased its holdings in Cellebrite DI by 68.3% during the 2nd quarter. Signaturefd LLC now owns 2,019 shares of the company’s stock worth $32,000 after purchasing an additional 819 shares in the last quarter. Catalyst Capital Advisors LLC acquired a new stake in shares of Cellebrite DI in the 1st quarter valued at about $51,000. Virtus Advisers LLC bought a new stake in shares of Cellebrite DI in the first quarter valued at about $63,000. Finally, Hennessy Advisors Inc. bought a new stake in shares of Cellebrite DI in the second quarter valued at about $83,000. Institutional investors and hedge funds own 45.88% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Wall Street Zen raised Cellebrite DI from a “hold” rating to a “buy” rating in a research report on Friday, September 26th. Needham & Company LLC cut their price objective on shares of Cellebrite DI from $24.00 to $18.00 and set a “buy” rating on the stock in a research report on Thursday, August 14th. Lake Street Capital reduced their target price on shares of Cellebrite DI from $24.00 to $22.00 and set a “buy” rating for the company in a report on Friday, August 15th. JPMorgan Chase & Co. lifted their price target on shares of Cellebrite DI from $20.00 to $23.00 and gave the company an “overweight” rating in a research note on Wednesday, September 24th. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Cellebrite DI in a research note on Wednesday, October 8th. Four analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $21.75.

Cellebrite DI Trading Up 0.4%

Shares of CLBT opened at $18.18 on Friday. The company’s fifty day simple moving average is $17.23 and its 200 day simple moving average is $16.94. Cellebrite DI Ltd. has a 1-year low of $13.10 and a 1-year high of $26.30. The company has a market cap of $4.35 billion, a price-to-earnings ratio of -23.92, a PEG ratio of 3.29 and a beta of 1.29.

Cellebrite DI (NASDAQ:CLBT) last announced its quarterly earnings results on Thursday, August 14th. The company reported $0.12 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.01. The firm had revenue of $113.28 million during the quarter, compared to analysts’ expectations of $112.33 million. Cellebrite DI had a negative net margin of 34.56% and a positive return on equity of 23.92%. The company’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.10 earnings per share. Cellebrite DI has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, research analysts forecast that Cellebrite DI Ltd. will post 0.3 earnings per share for the current year.

Cellebrite DI Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.